Regor Therapeutics Funding: $90M Raised, Series B (2021)
Regor Therapeutics is based in Shanghai, China. It has raised $90M in total funding. Latest round: Series B.
Regor Therapeutics funding overview
Regor Therapeutics is based in Shanghai, China. Regor Therapeutics has raised $90M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in February 2021. The round record for Regor Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Lilly Asia Ventures, Loyal Valley Capital, Lanting Capital, TF Capital, Vertex Ventures China, Qilu Pharmaceutical Group. 6 distinct backers are named across the disclosed rounds.
Regor Therapeutics at a glance
Total raised
$90M
Latest round
Series B
Latest round date
February 2021
Headquarters
Shanghai, China
Notable investors
Lilly Asia Ventures, Loyal Valley Capital, Lanting Capital, TF Capital, Vertex Ventures China, Qilu Pharmaceutical Group
Frequently asked about Regor Therapeutics funding
How much has Regor Therapeutics raised?
Regor Therapeutics has raised $90M in total disclosed funding across the rounds on record.
Who has invested in Regor Therapeutics?
Lilly Asia Ventures, Loyal Valley Capital, Lanting Capital, TF Capital, Vertex Ventures China, Qilu Pharmaceutical Group are named among the investors backing Regor Therapeutics.
What was the latest Regor Therapeutics funding round?
The most recent disclosed round is a Series B, announced in February 2021.
Where is Regor Therapeutics based?
Regor Therapeutics is based in Shanghai, China.
When did Regor Therapeutics last raise?
The last disclosed Regor Therapeutics round closed in February 2021 at Series B.
Totals shown for Regor Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Shanghai and the investors behind them below.
